Global Molecular Diagnostics Point of Care Supply, Demand and Key Producers, 2023-2029
The global Molecular Diagnostics Point of Care market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
The Molecular Diagnostics Point of Care enables physicians to improve the standard of care by combining rapid diagnosis with treatment decisions during the first patient visit.
This report studies the global Molecular Diagnostics Point of Care demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Molecular Diagnostics Point of Care, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Molecular Diagnostics Point of Care that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Molecular Diagnostics Point of Care total market, 2018-2029, (USD Million)
Global Molecular Diagnostics Point of Care total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Molecular Diagnostics Point of Care total market, key domestic companies and share, (USD Million)
Global Molecular Diagnostics Point of Care revenue by player and market share 2018-2023, (USD Million)
Global Molecular Diagnostics Point of Care total market by Type, CAGR, 2018-2029, (USD Million)
Global Molecular Diagnostics Point of Care total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Molecular Diagnostics Point of Care market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott Laboratories, Abaxis, Bayer Healthcare, Bio-Rad Laboratories, Becton Dickinson and Company, Binx Health, BioMerieux, Co-Diagnostics and DanaherCorporation, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Molecular Diagnostics Point of Care market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Molecular Diagnostics Point of Care Market, By Region:
1. How big is the global Molecular Diagnostics Point of Care market?
2. What is the demand of the global Molecular Diagnostics Point of Care market?
3. What is the year over year growth of the global Molecular Diagnostics Point of Care market?
4. What is the total value of the global Molecular Diagnostics Point of Care market?
5. Who are the major players in the global Molecular Diagnostics Point of Care market?
6. What are the growth factors driving the market demand?
The Molecular Diagnostics Point of Care enables physicians to improve the standard of care by combining rapid diagnosis with treatment decisions during the first patient visit.
This report studies the global Molecular Diagnostics Point of Care demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Molecular Diagnostics Point of Care, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Molecular Diagnostics Point of Care that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Molecular Diagnostics Point of Care total market, 2018-2029, (USD Million)
Global Molecular Diagnostics Point of Care total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Molecular Diagnostics Point of Care total market, key domestic companies and share, (USD Million)
Global Molecular Diagnostics Point of Care revenue by player and market share 2018-2023, (USD Million)
Global Molecular Diagnostics Point of Care total market by Type, CAGR, 2018-2029, (USD Million)
Global Molecular Diagnostics Point of Care total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Molecular Diagnostics Point of Care market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott Laboratories, Abaxis, Bayer Healthcare, Bio-Rad Laboratories, Becton Dickinson and Company, Binx Health, BioMerieux, Co-Diagnostics and DanaherCorporation, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Molecular Diagnostics Point of Care market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Molecular Diagnostics Point of Care Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Assays and Kits
- Instruments and Analyzers
- Software and Services
- Others
- Tumor
- Hematology
- Endocrinology
- Infectious Disease
- Others
- Abbott Laboratories
- Abaxis
- Bayer Healthcare
- Bio-Rad Laboratories
- Becton Dickinson and Company
- Binx Health
- BioMerieux
- Co-Diagnostics
- DanaherCorporation
- Dako
- F. Hoffmann
- OraSure Technologies
- Roche Diagnostics
- Nipro Diagnostics
- Genestat
- Meridian Bioscience
- Molbio Diagnostics
- Siemens Healthcare
- Thermo Fisher Scientific
- Visby Medical
- Wuhan Easy Diagnosis Biomedicine
- Beijing Tiandz
- Beijing Content
1. How big is the global Molecular Diagnostics Point of Care market?
2. What is the demand of the global Molecular Diagnostics Point of Care market?
3. What is the year over year growth of the global Molecular Diagnostics Point of Care market?
4. What is the total value of the global Molecular Diagnostics Point of Care market?
5. Who are the major players in the global Molecular Diagnostics Point of Care market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Molecular Diagnostics Point of Care Introduction
1.2 World Molecular Diagnostics Point of Care Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Molecular Diagnostics Point of Care Total Market by Region (by Headquarter Location)
1.3.1 World Molecular Diagnostics Point of Care Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Molecular Diagnostics Point of Care Market Size (2018-2029)
1.3.3 China Molecular Diagnostics Point of Care Market Size (2018-2029)
1.3.4 Europe Molecular Diagnostics Point of Care Market Size (2018-2029)
1.3.5 Japan Molecular Diagnostics Point of Care Market Size (2018-2029)
1.3.6 South Korea Molecular Diagnostics Point of Care Market Size (2018-2029)
1.3.7 ASEAN Molecular Diagnostics Point of Care Market Size (2018-2029)
1.3.8 India Molecular Diagnostics Point of Care Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Molecular Diagnostics Point of Care Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Molecular Diagnostics Point of Care Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Molecular Diagnostics Point of Care Consumption Value (2018-2029)
2.2 World Molecular Diagnostics Point of Care Consumption Value by Region
2.2.1 World Molecular Diagnostics Point of Care Consumption Value by Region (2018-2023)
2.2.2 World Molecular Diagnostics Point of Care Consumption Value Forecast by Region (2024-2029)
2.3 United States Molecular Diagnostics Point of Care Consumption Value (2018-2029)
2.4 China Molecular Diagnostics Point of Care Consumption Value (2018-2029)
2.5 Europe Molecular Diagnostics Point of Care Consumption Value (2018-2029)
2.6 Japan Molecular Diagnostics Point of Care Consumption Value (2018-2029)
2.7 South Korea Molecular Diagnostics Point of Care Consumption Value (2018-2029)
2.8 ASEAN Molecular Diagnostics Point of Care Consumption Value (2018-2029)
2.9 India Molecular Diagnostics Point of Care Consumption Value (2018-2029)
3 WORLD MOLECULAR DIAGNOSTICS POINT OF CARE COMPANIES COMPETITIVE ANALYSIS
3.1 World Molecular Diagnostics Point of Care Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Molecular Diagnostics Point of Care Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Molecular Diagnostics Point of Care in 2022
3.2.3 Global Concentration Ratios (CR8) for Molecular Diagnostics Point of Care in 2022
3.3 Molecular Diagnostics Point of Care Company Evaluation Quadrant
3.4 Molecular Diagnostics Point of Care Market: Overall Company Footprint Analysis
3.4.1 Molecular Diagnostics Point of Care Market: Region Footprint
3.4.2 Molecular Diagnostics Point of Care Market: Company Product Type Footprint
3.4.3 Molecular Diagnostics Point of Care Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Molecular Diagnostics Point of Care Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Molecular Diagnostics Point of Care Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Molecular Diagnostics Point of Care Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Molecular Diagnostics Point of Care Consumption Value Comparison
4.2.1 United States VS China: Molecular Diagnostics Point of Care Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Molecular Diagnostics Point of Care Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Molecular Diagnostics Point of Care Companies and Market Share, 2018-2023
4.3.1 United States Based Molecular Diagnostics Point of Care Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Molecular Diagnostics Point of Care Revenue, (2018-2023)
4.4 China Based Companies Molecular Diagnostics Point of Care Revenue and Market Share, 2018-2023
4.4.1 China Based Molecular Diagnostics Point of Care Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Molecular Diagnostics Point of Care Revenue, (2018-2023)
4.5 Rest of World Based Molecular Diagnostics Point of Care Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Molecular Diagnostics Point of Care Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Molecular Diagnostics Point of Care Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Molecular Diagnostics Point of Care Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Assays and Kits
5.2.2 Instruments and Analyzers
5.2.3 Software and Services
5.2.4 Others
5.3 Market Segment by Type
5.3.1 World Molecular Diagnostics Point of Care Market Size by Type (2018-2023)
5.3.2 World Molecular Diagnostics Point of Care Market Size by Type (2024-2029)
5.3.3 World Molecular Diagnostics Point of Care Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Molecular Diagnostics Point of Care Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Tumor
6.2.2 Hematology
6.2.3 Endocrinology
6.2.4 Infectious Disease
6.2.5 Infectious Disease
6.3 Market Segment by Application
6.3.1 World Molecular Diagnostics Point of Care Market Size by Application (2018-2023)
6.3.2 World Molecular Diagnostics Point of Care Market Size by Application (2024-2029)
6.3.3 World Molecular Diagnostics Point of Care Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Details
7.1.2 Abbott Laboratories Major Business
7.1.3 Abbott Laboratories Molecular Diagnostics Point of Care Product and Services
7.1.4 Abbott Laboratories Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Abbott Laboratories Recent Developments/Updates
7.1.6 Abbott Laboratories Competitive Strengths & Weaknesses
7.2 Abaxis
7.2.1 Abaxis Details
7.2.2 Abaxis Major Business
7.2.3 Abaxis Molecular Diagnostics Point of Care Product and Services
7.2.4 Abaxis Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Abaxis Recent Developments/Updates
7.2.6 Abaxis Competitive Strengths & Weaknesses
7.3 Bayer Healthcare
7.3.1 Bayer Healthcare Details
7.3.2 Bayer Healthcare Major Business
7.3.3 Bayer Healthcare Molecular Diagnostics Point of Care Product and Services
7.3.4 Bayer Healthcare Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Bayer Healthcare Recent Developments/Updates
7.3.6 Bayer Healthcare Competitive Strengths & Weaknesses
7.4 Bio-Rad Laboratories
7.4.1 Bio-Rad Laboratories Details
7.4.2 Bio-Rad Laboratories Major Business
7.4.3 Bio-Rad Laboratories Molecular Diagnostics Point of Care Product and Services
7.4.4 Bio-Rad Laboratories Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Bio-Rad Laboratories Recent Developments/Updates
7.4.6 Bio-Rad Laboratories Competitive Strengths & Weaknesses
7.5 Becton Dickinson and Company
7.5.1 Becton Dickinson and Company Details
7.5.2 Becton Dickinson and Company Major Business
7.5.3 Becton Dickinson and Company Molecular Diagnostics Point of Care Product and Services
7.5.4 Becton Dickinson and Company Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Becton Dickinson and Company Recent Developments/Updates
7.5.6 Becton Dickinson and Company Competitive Strengths & Weaknesses
7.6 Binx Health
7.6.1 Binx Health Details
7.6.2 Binx Health Major Business
7.6.3 Binx Health Molecular Diagnostics Point of Care Product and Services
7.6.4 Binx Health Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Binx Health Recent Developments/Updates
7.6.6 Binx Health Competitive Strengths & Weaknesses
7.7 BioMerieux
7.7.1 BioMerieux Details
7.7.2 BioMerieux Major Business
7.7.3 BioMerieux Molecular Diagnostics Point of Care Product and Services
7.7.4 BioMerieux Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 BioMerieux Recent Developments/Updates
7.7.6 BioMerieux Competitive Strengths & Weaknesses
7.8 Co-Diagnostics
7.8.1 Co-Diagnostics Details
7.8.2 Co-Diagnostics Major Business
7.8.3 Co-Diagnostics Molecular Diagnostics Point of Care Product and Services
7.8.4 Co-Diagnostics Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Co-Diagnostics Recent Developments/Updates
7.8.6 Co-Diagnostics Competitive Strengths & Weaknesses
7.9 DanaherCorporation
7.9.1 DanaherCorporation Details
7.9.2 DanaherCorporation Major Business
7.9.3 DanaherCorporation Molecular Diagnostics Point of Care Product and Services
7.9.4 DanaherCorporation Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 DanaherCorporation Recent Developments/Updates
7.9.6 DanaherCorporation Competitive Strengths & Weaknesses
7.10 Dako
7.10.1 Dako Details
7.10.2 Dako Major Business
7.10.3 Dako Molecular Diagnostics Point of Care Product and Services
7.10.4 Dako Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Dako Recent Developments/Updates
7.10.6 Dako Competitive Strengths & Weaknesses
7.11 F. Hoffmann
7.11.1 F. Hoffmann Details
7.11.2 F. Hoffmann Major Business
7.11.3 F. Hoffmann Molecular Diagnostics Point of Care Product and Services
7.11.4 F. Hoffmann Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 F. Hoffmann Recent Developments/Updates
7.11.6 F. Hoffmann Competitive Strengths & Weaknesses
7.12 OraSure Technologies
7.12.1 OraSure Technologies Details
7.12.2 OraSure Technologies Major Business
7.12.3 OraSure Technologies Molecular Diagnostics Point of Care Product and Services
7.12.4 OraSure Technologies Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 OraSure Technologies Recent Developments/Updates
7.12.6 OraSure Technologies Competitive Strengths & Weaknesses
7.13 Roche Diagnostics
7.13.1 Roche Diagnostics Details
7.13.2 Roche Diagnostics Major Business
7.13.3 Roche Diagnostics Molecular Diagnostics Point of Care Product and Services
7.13.4 Roche Diagnostics Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Roche Diagnostics Recent Developments/Updates
7.13.6 Roche Diagnostics Competitive Strengths & Weaknesses
7.14 Nipro Diagnostics
7.14.1 Nipro Diagnostics Details
7.14.2 Nipro Diagnostics Major Business
7.14.3 Nipro Diagnostics Molecular Diagnostics Point of Care Product and Services
7.14.4 Nipro Diagnostics Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Nipro Diagnostics Recent Developments/Updates
7.14.6 Nipro Diagnostics Competitive Strengths & Weaknesses
7.15 Genestat
7.15.1 Genestat Details
7.15.2 Genestat Major Business
7.15.3 Genestat Molecular Diagnostics Point of Care Product and Services
7.15.4 Genestat Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Genestat Recent Developments/Updates
7.15.6 Genestat Competitive Strengths & Weaknesses
7.16 Meridian Bioscience
7.16.1 Meridian Bioscience Details
7.16.2 Meridian Bioscience Major Business
7.16.3 Meridian Bioscience Molecular Diagnostics Point of Care Product and Services
7.16.4 Meridian Bioscience Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 Meridian Bioscience Recent Developments/Updates
7.16.6 Meridian Bioscience Competitive Strengths & Weaknesses
7.17 Molbio Diagnostics
7.17.1 Molbio Diagnostics Details
7.17.2 Molbio Diagnostics Major Business
7.17.3 Molbio Diagnostics Molecular Diagnostics Point of Care Product and Services
7.17.4 Molbio Diagnostics Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023)
7.17.5 Molbio Diagnostics Recent Developments/Updates
7.17.6 Molbio Diagnostics Competitive Strengths & Weaknesses
7.18 Siemens Healthcare
7.18.1 Siemens Healthcare Details
7.18.2 Siemens Healthcare Major Business
7.18.3 Siemens Healthcare Molecular Diagnostics Point of Care Product and Services
7.18.4 Siemens Healthcare Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023)
7.18.5 Siemens Healthcare Recent Developments/Updates
7.18.6 Siemens Healthcare Competitive Strengths & Weaknesses
7.19 Thermo Fisher Scientific
7.19.1 Thermo Fisher Scientific Details
7.19.2 Thermo Fisher Scientific Major Business
7.19.3 Thermo Fisher Scientific Molecular Diagnostics Point of Care Product and Services
7.19.4 Thermo Fisher Scientific Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023)
7.19.5 Thermo Fisher Scientific Recent Developments/Updates
7.19.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
7.20 Visby Medical
7.20.1 Visby Medical Details
7.20.2 Visby Medical Major Business
7.20.3 Visby Medical Molecular Diagnostics Point of Care Product and Services
7.20.4 Visby Medical Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023)
7.20.5 Visby Medical Recent Developments/Updates
7.20.6 Visby Medical Competitive Strengths & Weaknesses
7.21 Wuhan Easy Diagnosis Biomedicine
7.21.1 Wuhan Easy Diagnosis Biomedicine Details
7.21.2 Wuhan Easy Diagnosis Biomedicine Major Business
7.21.3 Wuhan Easy Diagnosis Biomedicine Molecular Diagnostics Point of Care Product and Services
7.21.4 Wuhan Easy Diagnosis Biomedicine Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023)
7.21.5 Wuhan Easy Diagnosis Biomedicine Recent Developments/Updates
7.21.6 Wuhan Easy Diagnosis Biomedicine Competitive Strengths & Weaknesses
7.22 Beijing Tiandz
7.22.1 Beijing Tiandz Details
7.22.2 Beijing Tiandz Major Business
7.22.3 Beijing Tiandz Molecular Diagnostics Point of Care Product and Services
7.22.4 Beijing Tiandz Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023)
7.22.5 Beijing Tiandz Recent Developments/Updates
7.22.6 Beijing Tiandz Competitive Strengths & Weaknesses
7.23 Beijing Content
7.23.1 Beijing Content Details
7.23.2 Beijing Content Major Business
7.23.3 Beijing Content Molecular Diagnostics Point of Care Product and Services
7.23.4 Beijing Content Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023)
7.23.5 Beijing Content Recent Developments/Updates
7.23.6 Beijing Content Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Molecular Diagnostics Point of Care Industry Chain
8.2 Molecular Diagnostics Point of Care Upstream Analysis
8.3 Molecular Diagnostics Point of Care Midstream Analysis
8.4 Molecular Diagnostics Point of Care Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Molecular Diagnostics Point of Care Introduction
1.2 World Molecular Diagnostics Point of Care Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Molecular Diagnostics Point of Care Total Market by Region (by Headquarter Location)
1.3.1 World Molecular Diagnostics Point of Care Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Molecular Diagnostics Point of Care Market Size (2018-2029)
1.3.3 China Molecular Diagnostics Point of Care Market Size (2018-2029)
1.3.4 Europe Molecular Diagnostics Point of Care Market Size (2018-2029)
1.3.5 Japan Molecular Diagnostics Point of Care Market Size (2018-2029)
1.3.6 South Korea Molecular Diagnostics Point of Care Market Size (2018-2029)
1.3.7 ASEAN Molecular Diagnostics Point of Care Market Size (2018-2029)
1.3.8 India Molecular Diagnostics Point of Care Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Molecular Diagnostics Point of Care Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Molecular Diagnostics Point of Care Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Molecular Diagnostics Point of Care Consumption Value (2018-2029)
2.2 World Molecular Diagnostics Point of Care Consumption Value by Region
2.2.1 World Molecular Diagnostics Point of Care Consumption Value by Region (2018-2023)
2.2.2 World Molecular Diagnostics Point of Care Consumption Value Forecast by Region (2024-2029)
2.3 United States Molecular Diagnostics Point of Care Consumption Value (2018-2029)
2.4 China Molecular Diagnostics Point of Care Consumption Value (2018-2029)
2.5 Europe Molecular Diagnostics Point of Care Consumption Value (2018-2029)
2.6 Japan Molecular Diagnostics Point of Care Consumption Value (2018-2029)
2.7 South Korea Molecular Diagnostics Point of Care Consumption Value (2018-2029)
2.8 ASEAN Molecular Diagnostics Point of Care Consumption Value (2018-2029)
2.9 India Molecular Diagnostics Point of Care Consumption Value (2018-2029)
3 WORLD MOLECULAR DIAGNOSTICS POINT OF CARE COMPANIES COMPETITIVE ANALYSIS
3.1 World Molecular Diagnostics Point of Care Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Molecular Diagnostics Point of Care Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Molecular Diagnostics Point of Care in 2022
3.2.3 Global Concentration Ratios (CR8) for Molecular Diagnostics Point of Care in 2022
3.3 Molecular Diagnostics Point of Care Company Evaluation Quadrant
3.4 Molecular Diagnostics Point of Care Market: Overall Company Footprint Analysis
3.4.1 Molecular Diagnostics Point of Care Market: Region Footprint
3.4.2 Molecular Diagnostics Point of Care Market: Company Product Type Footprint
3.4.3 Molecular Diagnostics Point of Care Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Molecular Diagnostics Point of Care Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Molecular Diagnostics Point of Care Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Molecular Diagnostics Point of Care Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Molecular Diagnostics Point of Care Consumption Value Comparison
4.2.1 United States VS China: Molecular Diagnostics Point of Care Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Molecular Diagnostics Point of Care Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Molecular Diagnostics Point of Care Companies and Market Share, 2018-2023
4.3.1 United States Based Molecular Diagnostics Point of Care Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Molecular Diagnostics Point of Care Revenue, (2018-2023)
4.4 China Based Companies Molecular Diagnostics Point of Care Revenue and Market Share, 2018-2023
4.4.1 China Based Molecular Diagnostics Point of Care Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Molecular Diagnostics Point of Care Revenue, (2018-2023)
4.5 Rest of World Based Molecular Diagnostics Point of Care Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Molecular Diagnostics Point of Care Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Molecular Diagnostics Point of Care Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Molecular Diagnostics Point of Care Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Assays and Kits
5.2.2 Instruments and Analyzers
5.2.3 Software and Services
5.2.4 Others
5.3 Market Segment by Type
5.3.1 World Molecular Diagnostics Point of Care Market Size by Type (2018-2023)
5.3.2 World Molecular Diagnostics Point of Care Market Size by Type (2024-2029)
5.3.3 World Molecular Diagnostics Point of Care Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Molecular Diagnostics Point of Care Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Tumor
6.2.2 Hematology
6.2.3 Endocrinology
6.2.4 Infectious Disease
6.2.5 Infectious Disease
6.3 Market Segment by Application
6.3.1 World Molecular Diagnostics Point of Care Market Size by Application (2018-2023)
6.3.2 World Molecular Diagnostics Point of Care Market Size by Application (2024-2029)
6.3.3 World Molecular Diagnostics Point of Care Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Details
7.1.2 Abbott Laboratories Major Business
7.1.3 Abbott Laboratories Molecular Diagnostics Point of Care Product and Services
7.1.4 Abbott Laboratories Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Abbott Laboratories Recent Developments/Updates
7.1.6 Abbott Laboratories Competitive Strengths & Weaknesses
7.2 Abaxis
7.2.1 Abaxis Details
7.2.2 Abaxis Major Business
7.2.3 Abaxis Molecular Diagnostics Point of Care Product and Services
7.2.4 Abaxis Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Abaxis Recent Developments/Updates
7.2.6 Abaxis Competitive Strengths & Weaknesses
7.3 Bayer Healthcare
7.3.1 Bayer Healthcare Details
7.3.2 Bayer Healthcare Major Business
7.3.3 Bayer Healthcare Molecular Diagnostics Point of Care Product and Services
7.3.4 Bayer Healthcare Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Bayer Healthcare Recent Developments/Updates
7.3.6 Bayer Healthcare Competitive Strengths & Weaknesses
7.4 Bio-Rad Laboratories
7.4.1 Bio-Rad Laboratories Details
7.4.2 Bio-Rad Laboratories Major Business
7.4.3 Bio-Rad Laboratories Molecular Diagnostics Point of Care Product and Services
7.4.4 Bio-Rad Laboratories Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Bio-Rad Laboratories Recent Developments/Updates
7.4.6 Bio-Rad Laboratories Competitive Strengths & Weaknesses
7.5 Becton Dickinson and Company
7.5.1 Becton Dickinson and Company Details
7.5.2 Becton Dickinson and Company Major Business
7.5.3 Becton Dickinson and Company Molecular Diagnostics Point of Care Product and Services
7.5.4 Becton Dickinson and Company Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Becton Dickinson and Company Recent Developments/Updates
7.5.6 Becton Dickinson and Company Competitive Strengths & Weaknesses
7.6 Binx Health
7.6.1 Binx Health Details
7.6.2 Binx Health Major Business
7.6.3 Binx Health Molecular Diagnostics Point of Care Product and Services
7.6.4 Binx Health Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Binx Health Recent Developments/Updates
7.6.6 Binx Health Competitive Strengths & Weaknesses
7.7 BioMerieux
7.7.1 BioMerieux Details
7.7.2 BioMerieux Major Business
7.7.3 BioMerieux Molecular Diagnostics Point of Care Product and Services
7.7.4 BioMerieux Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 BioMerieux Recent Developments/Updates
7.7.6 BioMerieux Competitive Strengths & Weaknesses
7.8 Co-Diagnostics
7.8.1 Co-Diagnostics Details
7.8.2 Co-Diagnostics Major Business
7.8.3 Co-Diagnostics Molecular Diagnostics Point of Care Product and Services
7.8.4 Co-Diagnostics Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Co-Diagnostics Recent Developments/Updates
7.8.6 Co-Diagnostics Competitive Strengths & Weaknesses
7.9 DanaherCorporation
7.9.1 DanaherCorporation Details
7.9.2 DanaherCorporation Major Business
7.9.3 DanaherCorporation Molecular Diagnostics Point of Care Product and Services
7.9.4 DanaherCorporation Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 DanaherCorporation Recent Developments/Updates
7.9.6 DanaherCorporation Competitive Strengths & Weaknesses
7.10 Dako
7.10.1 Dako Details
7.10.2 Dako Major Business
7.10.3 Dako Molecular Diagnostics Point of Care Product and Services
7.10.4 Dako Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Dako Recent Developments/Updates
7.10.6 Dako Competitive Strengths & Weaknesses
7.11 F. Hoffmann
7.11.1 F. Hoffmann Details
7.11.2 F. Hoffmann Major Business
7.11.3 F. Hoffmann Molecular Diagnostics Point of Care Product and Services
7.11.4 F. Hoffmann Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 F. Hoffmann Recent Developments/Updates
7.11.6 F. Hoffmann Competitive Strengths & Weaknesses
7.12 OraSure Technologies
7.12.1 OraSure Technologies Details
7.12.2 OraSure Technologies Major Business
7.12.3 OraSure Technologies Molecular Diagnostics Point of Care Product and Services
7.12.4 OraSure Technologies Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 OraSure Technologies Recent Developments/Updates
7.12.6 OraSure Technologies Competitive Strengths & Weaknesses
7.13 Roche Diagnostics
7.13.1 Roche Diagnostics Details
7.13.2 Roche Diagnostics Major Business
7.13.3 Roche Diagnostics Molecular Diagnostics Point of Care Product and Services
7.13.4 Roche Diagnostics Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Roche Diagnostics Recent Developments/Updates
7.13.6 Roche Diagnostics Competitive Strengths & Weaknesses
7.14 Nipro Diagnostics
7.14.1 Nipro Diagnostics Details
7.14.2 Nipro Diagnostics Major Business
7.14.3 Nipro Diagnostics Molecular Diagnostics Point of Care Product and Services
7.14.4 Nipro Diagnostics Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Nipro Diagnostics Recent Developments/Updates
7.14.6 Nipro Diagnostics Competitive Strengths & Weaknesses
7.15 Genestat
7.15.1 Genestat Details
7.15.2 Genestat Major Business
7.15.3 Genestat Molecular Diagnostics Point of Care Product and Services
7.15.4 Genestat Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Genestat Recent Developments/Updates
7.15.6 Genestat Competitive Strengths & Weaknesses
7.16 Meridian Bioscience
7.16.1 Meridian Bioscience Details
7.16.2 Meridian Bioscience Major Business
7.16.3 Meridian Bioscience Molecular Diagnostics Point of Care Product and Services
7.16.4 Meridian Bioscience Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 Meridian Bioscience Recent Developments/Updates
7.16.6 Meridian Bioscience Competitive Strengths & Weaknesses
7.17 Molbio Diagnostics
7.17.1 Molbio Diagnostics Details
7.17.2 Molbio Diagnostics Major Business
7.17.3 Molbio Diagnostics Molecular Diagnostics Point of Care Product and Services
7.17.4 Molbio Diagnostics Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023)
7.17.5 Molbio Diagnostics Recent Developments/Updates
7.17.6 Molbio Diagnostics Competitive Strengths & Weaknesses
7.18 Siemens Healthcare
7.18.1 Siemens Healthcare Details
7.18.2 Siemens Healthcare Major Business
7.18.3 Siemens Healthcare Molecular Diagnostics Point of Care Product and Services
7.18.4 Siemens Healthcare Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023)
7.18.5 Siemens Healthcare Recent Developments/Updates
7.18.6 Siemens Healthcare Competitive Strengths & Weaknesses
7.19 Thermo Fisher Scientific
7.19.1 Thermo Fisher Scientific Details
7.19.2 Thermo Fisher Scientific Major Business
7.19.3 Thermo Fisher Scientific Molecular Diagnostics Point of Care Product and Services
7.19.4 Thermo Fisher Scientific Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023)
7.19.5 Thermo Fisher Scientific Recent Developments/Updates
7.19.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
7.20 Visby Medical
7.20.1 Visby Medical Details
7.20.2 Visby Medical Major Business
7.20.3 Visby Medical Molecular Diagnostics Point of Care Product and Services
7.20.4 Visby Medical Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023)
7.20.5 Visby Medical Recent Developments/Updates
7.20.6 Visby Medical Competitive Strengths & Weaknesses
7.21 Wuhan Easy Diagnosis Biomedicine
7.21.1 Wuhan Easy Diagnosis Biomedicine Details
7.21.2 Wuhan Easy Diagnosis Biomedicine Major Business
7.21.3 Wuhan Easy Diagnosis Biomedicine Molecular Diagnostics Point of Care Product and Services
7.21.4 Wuhan Easy Diagnosis Biomedicine Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023)
7.21.5 Wuhan Easy Diagnosis Biomedicine Recent Developments/Updates
7.21.6 Wuhan Easy Diagnosis Biomedicine Competitive Strengths & Weaknesses
7.22 Beijing Tiandz
7.22.1 Beijing Tiandz Details
7.22.2 Beijing Tiandz Major Business
7.22.3 Beijing Tiandz Molecular Diagnostics Point of Care Product and Services
7.22.4 Beijing Tiandz Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023)
7.22.5 Beijing Tiandz Recent Developments/Updates
7.22.6 Beijing Tiandz Competitive Strengths & Weaknesses
7.23 Beijing Content
7.23.1 Beijing Content Details
7.23.2 Beijing Content Major Business
7.23.3 Beijing Content Molecular Diagnostics Point of Care Product and Services
7.23.4 Beijing Content Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023)
7.23.5 Beijing Content Recent Developments/Updates
7.23.6 Beijing Content Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Molecular Diagnostics Point of Care Industry Chain
8.2 Molecular Diagnostics Point of Care Upstream Analysis
8.3 Molecular Diagnostics Point of Care Midstream Analysis
8.4 Molecular Diagnostics Point of Care Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Molecular Diagnostics Point of Care Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Molecular Diagnostics Point of Care Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Molecular Diagnostics Point of Care Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Molecular Diagnostics Point of Care Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Molecular Diagnostics Point of Care Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Molecular Diagnostics Point of Care Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Molecular Diagnostics Point of Care Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Molecular Diagnostics Point of Care Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Molecular Diagnostics Point of Care Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Molecular Diagnostics Point of Care Players in 2022
Table 12. World Molecular Diagnostics Point of Care Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Molecular Diagnostics Point of Care Company Evaluation Quadrant
Table 14. Head Office of Key Molecular Diagnostics Point of Care Player
Table 15. Molecular Diagnostics Point of Care Market: Company Product Type Footprint
Table 16. Molecular Diagnostics Point of Care Market: Company Product Application Footprint
Table 17. Molecular Diagnostics Point of Care Mergers & Acquisitions Activity
Table 18. United States VS China Molecular Diagnostics Point of Care Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Molecular Diagnostics Point of Care Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Molecular Diagnostics Point of Care Companies, Headquarters (States, Country)
Table 21. United States Based Companies Molecular Diagnostics Point of Care Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Molecular Diagnostics Point of Care Revenue Market Share (2018-2023)
Table 23. China Based Molecular Diagnostics Point of Care Companies, Headquarters (Province, Country)
Table 24. China Based Companies Molecular Diagnostics Point of Care Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Molecular Diagnostics Point of Care Revenue Market Share (2018-2023)
Table 26. Rest of World Based Molecular Diagnostics Point of Care Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Molecular Diagnostics Point of Care Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Molecular Diagnostics Point of Care Revenue Market Share (2018-2023)
Table 29. World Molecular Diagnostics Point of Care Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Molecular Diagnostics Point of Care Market Size by Type (2018-2023) & (USD Million)
Table 31. World Molecular Diagnostics Point of Care Market Size by Type (2024-2029) & (USD Million)
Table 32. World Molecular Diagnostics Point of Care Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Molecular Diagnostics Point of Care Market Size by Application (2018-2023) & (USD Million)
Table 34. World Molecular Diagnostics Point of Care Market Size by Application (2024-2029) & (USD Million)
Table 35. Abbott Laboratories Basic Information, Area Served and Competitors
Table 36. Abbott Laboratories Major Business
Table 37. Abbott Laboratories Molecular Diagnostics Point of Care Product and Services
Table 38. Abbott Laboratories Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Abbott Laboratories Recent Developments/Updates
Table 40. Abbott Laboratories Competitive Strengths & Weaknesses
Table 41. Abaxis Basic Information, Area Served and Competitors
Table 42. Abaxis Major Business
Table 43. Abaxis Molecular Diagnostics Point of Care Product and Services
Table 44. Abaxis Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Abaxis Recent Developments/Updates
Table 46. Abaxis Competitive Strengths & Weaknesses
Table 47. Bayer Healthcare Basic Information, Area Served and Competitors
Table 48. Bayer Healthcare Major Business
Table 49. Bayer Healthcare Molecular Diagnostics Point of Care Product and Services
Table 50. Bayer Healthcare Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Bayer Healthcare Recent Developments/Updates
Table 52. Bayer Healthcare Competitive Strengths & Weaknesses
Table 53. Bio-Rad Laboratories Basic Information, Area Served and Competitors
Table 54. Bio-Rad Laboratories Major Business
Table 55. Bio-Rad Laboratories Molecular Diagnostics Point of Care Product and Services
Table 56. Bio-Rad Laboratories Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Bio-Rad Laboratories Recent Developments/Updates
Table 58. Bio-Rad Laboratories Competitive Strengths & Weaknesses
Table 59. Becton Dickinson and Company Basic Information, Area Served and Competitors
Table 60. Becton Dickinson and Company Major Business
Table 61. Becton Dickinson and Company Molecular Diagnostics Point of Care Product and Services
Table 62. Becton Dickinson and Company Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Becton Dickinson and Company Recent Developments/Updates
Table 64. Becton Dickinson and Company Competitive Strengths & Weaknesses
Table 65. Binx Health Basic Information, Area Served and Competitors
Table 66. Binx Health Major Business
Table 67. Binx Health Molecular Diagnostics Point of Care Product and Services
Table 68. Binx Health Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Binx Health Recent Developments/Updates
Table 70. Binx Health Competitive Strengths & Weaknesses
Table 71. BioMerieux Basic Information, Area Served and Competitors
Table 72. BioMerieux Major Business
Table 73. BioMerieux Molecular Diagnostics Point of Care Product and Services
Table 74. BioMerieux Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. BioMerieux Recent Developments/Updates
Table 76. BioMerieux Competitive Strengths & Weaknesses
Table 77. Co-Diagnostics Basic Information, Area Served and Competitors
Table 78. Co-Diagnostics Major Business
Table 79. Co-Diagnostics Molecular Diagnostics Point of Care Product and Services
Table 80. Co-Diagnostics Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Co-Diagnostics Recent Developments/Updates
Table 82. Co-Diagnostics Competitive Strengths & Weaknesses
Table 83. DanaherCorporation Basic Information, Area Served and Competitors
Table 84. DanaherCorporation Major Business
Table 85. DanaherCorporation Molecular Diagnostics Point of Care Product and Services
Table 86. DanaherCorporation Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. DanaherCorporation Recent Developments/Updates
Table 88. DanaherCorporation Competitive Strengths & Weaknesses
Table 89. Dako Basic Information, Area Served and Competitors
Table 90. Dako Major Business
Table 91. Dako Molecular Diagnostics Point of Care Product and Services
Table 92. Dako Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Dako Recent Developments/Updates
Table 94. Dako Competitive Strengths & Weaknesses
Table 95. F. Hoffmann Basic Information, Area Served and Competitors
Table 96. F. Hoffmann Major Business
Table 97. F. Hoffmann Molecular Diagnostics Point of Care Product and Services
Table 98. F. Hoffmann Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. F. Hoffmann Recent Developments/Updates
Table 100. F. Hoffmann Competitive Strengths & Weaknesses
Table 101. OraSure Technologies Basic Information, Area Served and Competitors
Table 102. OraSure Technologies Major Business
Table 103. OraSure Technologies Molecular Diagnostics Point of Care Product and Services
Table 104. OraSure Technologies Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. OraSure Technologies Recent Developments/Updates
Table 106. OraSure Technologies Competitive Strengths & Weaknesses
Table 107. Roche Diagnostics Basic Information, Area Served and Competitors
Table 108. Roche Diagnostics Major Business
Table 109. Roche Diagnostics Molecular Diagnostics Point of Care Product and Services
Table 110. Roche Diagnostics Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Roche Diagnostics Recent Developments/Updates
Table 112. Roche Diagnostics Competitive Strengths & Weaknesses
Table 113. Nipro Diagnostics Basic Information, Area Served and Competitors
Table 114. Nipro Diagnostics Major Business
Table 115. Nipro Diagnostics Molecular Diagnostics Point of Care Product and Services
Table 116. Nipro Diagnostics Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Nipro Diagnostics Recent Developments/Updates
Table 118. Nipro Diagnostics Competitive Strengths & Weaknesses
Table 119. Genestat Basic Information, Area Served and Competitors
Table 120. Genestat Major Business
Table 121. Genestat Molecular Diagnostics Point of Care Product and Services
Table 122. Genestat Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. Genestat Recent Developments/Updates
Table 124. Genestat Competitive Strengths & Weaknesses
Table 125. Meridian Bioscience Basic Information, Area Served and Competitors
Table 126. Meridian Bioscience Major Business
Table 127. Meridian Bioscience Molecular Diagnostics Point of Care Product and Services
Table 128. Meridian Bioscience Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. Meridian Bioscience Recent Developments/Updates
Table 130. Meridian Bioscience Competitive Strengths & Weaknesses
Table 131. Molbio Diagnostics Basic Information, Area Served and Competitors
Table 132. Molbio Diagnostics Major Business
Table 133. Molbio Diagnostics Molecular Diagnostics Point of Care Product and Services
Table 134. Molbio Diagnostics Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 135. Molbio Diagnostics Recent Developments/Updates
Table 136. Molbio Diagnostics Competitive Strengths & Weaknesses
Table 137. Siemens Healthcare Basic Information, Area Served and Competitors
Table 138. Siemens Healthcare Major Business
Table 139. Siemens Healthcare Molecular Diagnostics Point of Care Product and Services
Table 140. Siemens Healthcare Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 141. Siemens Healthcare Recent Developments/Updates
Table 142. Siemens Healthcare Competitive Strengths & Weaknesses
Table 143. Thermo Fisher Scientific Basic Information, Area Served and Competitors
Table 144. Thermo Fisher Scientific Major Business
Table 145. Thermo Fisher Scientific Molecular Diagnostics Point of Care Product and Services
Table 146. Thermo Fisher Scientific Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 147. Thermo Fisher Scientific Recent Developments/Updates
Table 148. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 149. Visby Medical Basic Information, Area Served and Competitors
Table 150. Visby Medical Major Business
Table 151. Visby Medical Molecular Diagnostics Point of Care Product and Services
Table 152. Visby Medical Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 153. Visby Medical Recent Developments/Updates
Table 154. Visby Medical Competitive Strengths & Weaknesses
Table 155. Wuhan Easy Diagnosis Biomedicine Basic Information, Area Served and Competitors
Table 156. Wuhan Easy Diagnosis Biomedicine Major Business
Table 157. Wuhan Easy Diagnosis Biomedicine Molecular Diagnostics Point of Care Product and Services
Table 158. Wuhan Easy Diagnosis Biomedicine Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 159. Wuhan Easy Diagnosis Biomedicine Recent Developments/Updates
Table 160. Wuhan Easy Diagnosis Biomedicine Competitive Strengths & Weaknesses
Table 161. Beijing Tiandz Basic Information, Area Served and Competitors
Table 162. Beijing Tiandz Major Business
Table 163. Beijing Tiandz Molecular Diagnostics Point of Care Product and Services
Table 164. Beijing Tiandz Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 165. Beijing Tiandz Recent Developments/Updates
Table 166. Beijing Content Basic Information, Area Served and Competitors
Table 167. Beijing Content Major Business
Table 168. Beijing Content Molecular Diagnostics Point of Care Product and Services
Table 169. Beijing Content Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 170. Global Key Players of Molecular Diagnostics Point of Care Upstream (Raw Materials)
Table 171. Molecular Diagnostics Point of Care Typical Customers
Table 1. World Molecular Diagnostics Point of Care Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Molecular Diagnostics Point of Care Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Molecular Diagnostics Point of Care Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Molecular Diagnostics Point of Care Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Molecular Diagnostics Point of Care Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Molecular Diagnostics Point of Care Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Molecular Diagnostics Point of Care Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Molecular Diagnostics Point of Care Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Molecular Diagnostics Point of Care Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Molecular Diagnostics Point of Care Players in 2022
Table 12. World Molecular Diagnostics Point of Care Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Molecular Diagnostics Point of Care Company Evaluation Quadrant
Table 14. Head Office of Key Molecular Diagnostics Point of Care Player
Table 15. Molecular Diagnostics Point of Care Market: Company Product Type Footprint
Table 16. Molecular Diagnostics Point of Care Market: Company Product Application Footprint
Table 17. Molecular Diagnostics Point of Care Mergers & Acquisitions Activity
Table 18. United States VS China Molecular Diagnostics Point of Care Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Molecular Diagnostics Point of Care Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Molecular Diagnostics Point of Care Companies, Headquarters (States, Country)
Table 21. United States Based Companies Molecular Diagnostics Point of Care Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Molecular Diagnostics Point of Care Revenue Market Share (2018-2023)
Table 23. China Based Molecular Diagnostics Point of Care Companies, Headquarters (Province, Country)
Table 24. China Based Companies Molecular Diagnostics Point of Care Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Molecular Diagnostics Point of Care Revenue Market Share (2018-2023)
Table 26. Rest of World Based Molecular Diagnostics Point of Care Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Molecular Diagnostics Point of Care Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Molecular Diagnostics Point of Care Revenue Market Share (2018-2023)
Table 29. World Molecular Diagnostics Point of Care Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Molecular Diagnostics Point of Care Market Size by Type (2018-2023) & (USD Million)
Table 31. World Molecular Diagnostics Point of Care Market Size by Type (2024-2029) & (USD Million)
Table 32. World Molecular Diagnostics Point of Care Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Molecular Diagnostics Point of Care Market Size by Application (2018-2023) & (USD Million)
Table 34. World Molecular Diagnostics Point of Care Market Size by Application (2024-2029) & (USD Million)
Table 35. Abbott Laboratories Basic Information, Area Served and Competitors
Table 36. Abbott Laboratories Major Business
Table 37. Abbott Laboratories Molecular Diagnostics Point of Care Product and Services
Table 38. Abbott Laboratories Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Abbott Laboratories Recent Developments/Updates
Table 40. Abbott Laboratories Competitive Strengths & Weaknesses
Table 41. Abaxis Basic Information, Area Served and Competitors
Table 42. Abaxis Major Business
Table 43. Abaxis Molecular Diagnostics Point of Care Product and Services
Table 44. Abaxis Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Abaxis Recent Developments/Updates
Table 46. Abaxis Competitive Strengths & Weaknesses
Table 47. Bayer Healthcare Basic Information, Area Served and Competitors
Table 48. Bayer Healthcare Major Business
Table 49. Bayer Healthcare Molecular Diagnostics Point of Care Product and Services
Table 50. Bayer Healthcare Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Bayer Healthcare Recent Developments/Updates
Table 52. Bayer Healthcare Competitive Strengths & Weaknesses
Table 53. Bio-Rad Laboratories Basic Information, Area Served and Competitors
Table 54. Bio-Rad Laboratories Major Business
Table 55. Bio-Rad Laboratories Molecular Diagnostics Point of Care Product and Services
Table 56. Bio-Rad Laboratories Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Bio-Rad Laboratories Recent Developments/Updates
Table 58. Bio-Rad Laboratories Competitive Strengths & Weaknesses
Table 59. Becton Dickinson and Company Basic Information, Area Served and Competitors
Table 60. Becton Dickinson and Company Major Business
Table 61. Becton Dickinson and Company Molecular Diagnostics Point of Care Product and Services
Table 62. Becton Dickinson and Company Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Becton Dickinson and Company Recent Developments/Updates
Table 64. Becton Dickinson and Company Competitive Strengths & Weaknesses
Table 65. Binx Health Basic Information, Area Served and Competitors
Table 66. Binx Health Major Business
Table 67. Binx Health Molecular Diagnostics Point of Care Product and Services
Table 68. Binx Health Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Binx Health Recent Developments/Updates
Table 70. Binx Health Competitive Strengths & Weaknesses
Table 71. BioMerieux Basic Information, Area Served and Competitors
Table 72. BioMerieux Major Business
Table 73. BioMerieux Molecular Diagnostics Point of Care Product and Services
Table 74. BioMerieux Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. BioMerieux Recent Developments/Updates
Table 76. BioMerieux Competitive Strengths & Weaknesses
Table 77. Co-Diagnostics Basic Information, Area Served and Competitors
Table 78. Co-Diagnostics Major Business
Table 79. Co-Diagnostics Molecular Diagnostics Point of Care Product and Services
Table 80. Co-Diagnostics Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Co-Diagnostics Recent Developments/Updates
Table 82. Co-Diagnostics Competitive Strengths & Weaknesses
Table 83. DanaherCorporation Basic Information, Area Served and Competitors
Table 84. DanaherCorporation Major Business
Table 85. DanaherCorporation Molecular Diagnostics Point of Care Product and Services
Table 86. DanaherCorporation Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. DanaherCorporation Recent Developments/Updates
Table 88. DanaherCorporation Competitive Strengths & Weaknesses
Table 89. Dako Basic Information, Area Served and Competitors
Table 90. Dako Major Business
Table 91. Dako Molecular Diagnostics Point of Care Product and Services
Table 92. Dako Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Dako Recent Developments/Updates
Table 94. Dako Competitive Strengths & Weaknesses
Table 95. F. Hoffmann Basic Information, Area Served and Competitors
Table 96. F. Hoffmann Major Business
Table 97. F. Hoffmann Molecular Diagnostics Point of Care Product and Services
Table 98. F. Hoffmann Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. F. Hoffmann Recent Developments/Updates
Table 100. F. Hoffmann Competitive Strengths & Weaknesses
Table 101. OraSure Technologies Basic Information, Area Served and Competitors
Table 102. OraSure Technologies Major Business
Table 103. OraSure Technologies Molecular Diagnostics Point of Care Product and Services
Table 104. OraSure Technologies Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. OraSure Technologies Recent Developments/Updates
Table 106. OraSure Technologies Competitive Strengths & Weaknesses
Table 107. Roche Diagnostics Basic Information, Area Served and Competitors
Table 108. Roche Diagnostics Major Business
Table 109. Roche Diagnostics Molecular Diagnostics Point of Care Product and Services
Table 110. Roche Diagnostics Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Roche Diagnostics Recent Developments/Updates
Table 112. Roche Diagnostics Competitive Strengths & Weaknesses
Table 113. Nipro Diagnostics Basic Information, Area Served and Competitors
Table 114. Nipro Diagnostics Major Business
Table 115. Nipro Diagnostics Molecular Diagnostics Point of Care Product and Services
Table 116. Nipro Diagnostics Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Nipro Diagnostics Recent Developments/Updates
Table 118. Nipro Diagnostics Competitive Strengths & Weaknesses
Table 119. Genestat Basic Information, Area Served and Competitors
Table 120. Genestat Major Business
Table 121. Genestat Molecular Diagnostics Point of Care Product and Services
Table 122. Genestat Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. Genestat Recent Developments/Updates
Table 124. Genestat Competitive Strengths & Weaknesses
Table 125. Meridian Bioscience Basic Information, Area Served and Competitors
Table 126. Meridian Bioscience Major Business
Table 127. Meridian Bioscience Molecular Diagnostics Point of Care Product and Services
Table 128. Meridian Bioscience Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. Meridian Bioscience Recent Developments/Updates
Table 130. Meridian Bioscience Competitive Strengths & Weaknesses
Table 131. Molbio Diagnostics Basic Information, Area Served and Competitors
Table 132. Molbio Diagnostics Major Business
Table 133. Molbio Diagnostics Molecular Diagnostics Point of Care Product and Services
Table 134. Molbio Diagnostics Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 135. Molbio Diagnostics Recent Developments/Updates
Table 136. Molbio Diagnostics Competitive Strengths & Weaknesses
Table 137. Siemens Healthcare Basic Information, Area Served and Competitors
Table 138. Siemens Healthcare Major Business
Table 139. Siemens Healthcare Molecular Diagnostics Point of Care Product and Services
Table 140. Siemens Healthcare Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 141. Siemens Healthcare Recent Developments/Updates
Table 142. Siemens Healthcare Competitive Strengths & Weaknesses
Table 143. Thermo Fisher Scientific Basic Information, Area Served and Competitors
Table 144. Thermo Fisher Scientific Major Business
Table 145. Thermo Fisher Scientific Molecular Diagnostics Point of Care Product and Services
Table 146. Thermo Fisher Scientific Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 147. Thermo Fisher Scientific Recent Developments/Updates
Table 148. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 149. Visby Medical Basic Information, Area Served and Competitors
Table 150. Visby Medical Major Business
Table 151. Visby Medical Molecular Diagnostics Point of Care Product and Services
Table 152. Visby Medical Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 153. Visby Medical Recent Developments/Updates
Table 154. Visby Medical Competitive Strengths & Weaknesses
Table 155. Wuhan Easy Diagnosis Biomedicine Basic Information, Area Served and Competitors
Table 156. Wuhan Easy Diagnosis Biomedicine Major Business
Table 157. Wuhan Easy Diagnosis Biomedicine Molecular Diagnostics Point of Care Product and Services
Table 158. Wuhan Easy Diagnosis Biomedicine Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 159. Wuhan Easy Diagnosis Biomedicine Recent Developments/Updates
Table 160. Wuhan Easy Diagnosis Biomedicine Competitive Strengths & Weaknesses
Table 161. Beijing Tiandz Basic Information, Area Served and Competitors
Table 162. Beijing Tiandz Major Business
Table 163. Beijing Tiandz Molecular Diagnostics Point of Care Product and Services
Table 164. Beijing Tiandz Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 165. Beijing Tiandz Recent Developments/Updates
Table 166. Beijing Content Basic Information, Area Served and Competitors
Table 167. Beijing Content Major Business
Table 168. Beijing Content Molecular Diagnostics Point of Care Product and Services
Table 169. Beijing Content Molecular Diagnostics Point of Care Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 170. Global Key Players of Molecular Diagnostics Point of Care Upstream (Raw Materials)
Table 171. Molecular Diagnostics Point of Care Typical Customers
LIST OF FIGURES
Figure 1. Molecular Diagnostics Point of Care Picture
Figure 2. World Molecular Diagnostics Point of Care Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Molecular Diagnostics Point of Care Total Market Size (2018-2029) & (USD Million)
Figure 4. World Molecular Diagnostics Point of Care Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Molecular Diagnostics Point of Care Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Molecular Diagnostics Point of Care Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Molecular Diagnostics Point of Care Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Molecular Diagnostics Point of Care Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Molecular Diagnostics Point of Care Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Molecular Diagnostics Point of Care Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Molecular Diagnostics Point of Care Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Molecular Diagnostics Point of Care Revenue (2018-2029) & (USD Million)
Figure 13. Molecular Diagnostics Point of Care Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Molecular Diagnostics Point of Care Consumption Value (2018-2029) & (USD Million)
Figure 16. World Molecular Diagnostics Point of Care Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Molecular Diagnostics Point of Care Consumption Value (2018-2029) & (USD Million)
Figure 18. China Molecular Diagnostics Point of Care Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Molecular Diagnostics Point of Care Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Molecular Diagnostics Point of Care Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Molecular Diagnostics Point of Care Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Molecular Diagnostics Point of Care Consumption Value (2018-2029) & (USD Million)
Figure 23. India Molecular Diagnostics Point of Care Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Molecular Diagnostics Point of Care by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Molecular Diagnostics Point of Care Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Molecular Diagnostics Point of Care Markets in 2022
Figure 27. United States VS China: Molecular Diagnostics Point of Care Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Molecular Diagnostics Point of Care Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Molecular Diagnostics Point of Care Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Molecular Diagnostics Point of Care Market Size Market Share by Type in 2022
Figure 31. Assays and Kits
Figure 32. Instruments and Analyzers
Figure 33. Software and Services
Figure 34. Others
Figure 35. World Molecular Diagnostics Point of Care Market Size Market Share by Type (2018-2029)
Figure 36. World Molecular Diagnostics Point of Care Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 37. World Molecular Diagnostics Point of Care Market Size Market Share by Application in 2022
Figure 38. Tumor
Figure 39. Hematology
Figure 40. Endocrinology
Figure 41. Infectious Disease
Figure 42. Others
Figure 43. Molecular Diagnostics Point of Care Industrial Chain
Figure 44. Methodology
Figure 45. Research Process and Data Source
Figure 1. Molecular Diagnostics Point of Care Picture
Figure 2. World Molecular Diagnostics Point of Care Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Molecular Diagnostics Point of Care Total Market Size (2018-2029) & (USD Million)
Figure 4. World Molecular Diagnostics Point of Care Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Molecular Diagnostics Point of Care Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Molecular Diagnostics Point of Care Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Molecular Diagnostics Point of Care Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Molecular Diagnostics Point of Care Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Molecular Diagnostics Point of Care Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Molecular Diagnostics Point of Care Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Molecular Diagnostics Point of Care Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Molecular Diagnostics Point of Care Revenue (2018-2029) & (USD Million)
Figure 13. Molecular Diagnostics Point of Care Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Molecular Diagnostics Point of Care Consumption Value (2018-2029) & (USD Million)
Figure 16. World Molecular Diagnostics Point of Care Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Molecular Diagnostics Point of Care Consumption Value (2018-2029) & (USD Million)
Figure 18. China Molecular Diagnostics Point of Care Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Molecular Diagnostics Point of Care Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Molecular Diagnostics Point of Care Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Molecular Diagnostics Point of Care Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Molecular Diagnostics Point of Care Consumption Value (2018-2029) & (USD Million)
Figure 23. India Molecular Diagnostics Point of Care Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Molecular Diagnostics Point of Care by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Molecular Diagnostics Point of Care Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Molecular Diagnostics Point of Care Markets in 2022
Figure 27. United States VS China: Molecular Diagnostics Point of Care Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Molecular Diagnostics Point of Care Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Molecular Diagnostics Point of Care Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Molecular Diagnostics Point of Care Market Size Market Share by Type in 2022
Figure 31. Assays and Kits
Figure 32. Instruments and Analyzers
Figure 33. Software and Services
Figure 34. Others
Figure 35. World Molecular Diagnostics Point of Care Market Size Market Share by Type (2018-2029)
Figure 36. World Molecular Diagnostics Point of Care Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 37. World Molecular Diagnostics Point of Care Market Size Market Share by Application in 2022
Figure 38. Tumor
Figure 39. Hematology
Figure 40. Endocrinology
Figure 41. Infectious Disease
Figure 42. Others
Figure 43. Molecular Diagnostics Point of Care Industrial Chain
Figure 44. Methodology
Figure 45. Research Process and Data Source
